Number and rate* of newly reported cases† of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2020
Downloads of this table: PDF PPT
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For case definition, see Chronic Hepatitis B.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statue, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
In the United States, chronic hepatitis B is one of the leading causes of cirrhosis, which is a major cause of liver cancer. This table displays the number and rates of newly identified chronic hepatitis B cases during 2020, by state or jurisdiction. In 2020, chronic hepatitis B was not a reportable condition in five states (Arkansas, Connecticut, Kentucky, Mississippi, and Texas).
Cases were unavailable from six states or jurisdictions (District of Columbia, Hawaii, Nevada, New Hampshire, Rhode Island), and no cases were reported by two states (Alabama and California). Of note, cases of newly reported chronic hepatitis B do not represent all prevalent hepatitis B infections, which cannot be captured in the National Notifiable Diseases Surveillance System.
Of the 11,635 cases of newly reported chronic hepatitis B reported during 2020, approximately half of the cases were from 5 states (Florida, New York, Georgia, Pennsylvania, and Ohio). The highest rate of newly reported chronic hepatitis B was in Oklahoma (9.7 cases per 100,000 population), whereas the lowest rates were in Arizona and Wisconsin (0.6 cases per 100,000 population).
- Figure 2.1. Number of reported cases of acute hepatitis B virus infection and estimated infections — United States, 2013-2020
- Figure 2.2. Rates of reported acute hepatitis B virus infection†, by state or jurisdiction — United States, 2019-2020
- Figure 2.3. Rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2020
- Figure 2.4. Rates of reported cases of acute hepatitis B virus infection, by age group — United States, 2005-2020
- Figure 2.5. Rates of reported cases of acute hepatitis B virus infection, by sex — United States, 2005-2020
- Figure 2.6. Rates of reported cases of acute hepatitis B virus infection, by race/ethnicity — United States, 2005-2020
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2020
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2020
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2016-2020
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States 2016-2020
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2020
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2020
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2020
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2020
- Table 2.7. Numbers and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2016-2020
- Table 2.8. Numbers and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2016-2020